Afficher la notice abrégée
| dc.contributor.author |
CHENTLI, Amira |
|
| dc.contributor.author |
BENHAMDI, Asma |
|
| dc.contributor.author |
HARZALLAH, Besma |
|
| dc.contributor.author |
BOUKALA, Rahil |
|
| dc.contributor.author |
REFAH, Rawia |
|
| dc.date.accessioned |
2026-01-11T10:24:06Z |
|
| dc.date.available |
2026-01-11T10:24:06Z |
|
| dc.date.issued |
2023-10-05 |
|
| dc.identifier.uri |
http://depot.umc.edu.dz/handle/123456789/14765 |
|
| dc.description.abstract |
Blood transfusion is a life saving intervention and plays a vital role in the
management of patients in the health care system. Medical interview is the first barrier to select at-risk
individuals.
Objectives: The objective of this work was to determine the prevalence of human
immunodeficiency virus (HIV), hepatitis B virus (HBV), C (HCV) and syphilis on blood donations
collected at the blood transfusion center CTS/EHS DAKSI.
Methods: blood test data was collected over a period of three years
Results and discussion: A retrospective study of 10949 samples revealed that the majority of
donors were less than 36 years (62.11%) in both sexes. In addition, a male predominance was noted,
with a value of 71%. Occasional donors are largely in favor compared to regular donors. The total
number of blood donors from fixed and mobile collect is almost equal (47% and 53% respectively). In
general, the prevalence assessment shows low levels for the studied infectious markers, with the highest
value noted for HBV (0.14%) followed by that of syphilis (0.13%). On the other hand, the
seroprevalence of HCV is much lower with an average of 0.013%, and that of HIV is zero (0%).
Conclusion: The low rates of seroprevalence observed in this study show the improvement of
preventive measures with regard to donor selection and screening tests |
fr_FR |
| dc.language.iso |
en |
fr_FR |
| dc.publisher |
université frères mentouri constantine1 |
fr_FR |
| dc.subject |
Biological screening |
fr_FR |
| dc.subject |
ELISA |
fr_FR |
| dc.subject |
blood donations |
fr_FR |
| dc.subject |
blood-borne disease |
fr_FR |
| dc.title |
HP-14: Screening of diseases transmitted through blood and their preventions |
fr_FR |
| dc.type |
Article |
fr_FR |
Fichier(s) constituant ce document
Ce document figure dans la(les) collection(s) suivante(s)
Afficher la notice abrégée